News Online
  • Sign in
  • News
    • Africa
    • Americas
      • Law
      • Politics
        • 2020 Election
    • Asia
    • Australia
    • Canada
    • China
    • Europe
    • India
    • Latin America
    • Middle East
      • Israel
        • Israel Election
    • Russia
    • UK
  • Economy
    • Business
    • Health
      • Medicine
    • Industrial
    • Markets
    • Real Estate
    • Small Business
    • Startup
  • Science & Technology
    • Apps
    • Cameras
    • Space
    • Computers
    • Phones
    • Gadgets
    • Internet
  • Food & Drinks
    • Restaurants
  • Culture
    • Art
    • Books
    • Celebrity
    • Movies
    • Music
    • TV
  • LifeStyle
    • Autos
    • Fitness
    • Fashion
      • Beauty
    • Design
  • Sports
    • American Football
    • Athletics
    • Bastketball
    • Cycling
    • Football
    • Golf
    • Motorsport
      • Formula 1
      • Indycar
      • Nascar
    • Tennis
  • Travel
    • Africa
    • Asia
      • Thiland
    • Europe
    • India
    • Middle East
      • Israel
    • North America
    • South America
    • UK & Ireland
    • United States
  • Login
Menu
  • Sign in
  • News
    • Africa
    • Americas
      • Law
      • Politics
        • 2020 Election
    • Asia
    • Australia
    • Canada
    • China
    • Europe
    • India
    • Latin America
    • Middle East
      • Israel
        • Israel Election
    • Russia
    • UK
  • Economy
    • Business
    • Health
      • Medicine
    • Industrial
    • Markets
    • Real Estate
    • Small Business
    • Startup
  • Science & Technology
    • Apps
    • Cameras
    • Space
    • Computers
    • Phones
    • Gadgets
    • Internet
  • Food & Drinks
    • Restaurants
  • Culture
    • Art
    • Books
    • Celebrity
    • Movies
    • Music
    • TV
  • LifeStyle
    • Autos
    • Fitness
    • Fashion
      • Beauty
    • Design
  • Sports
    • American Football
    • Athletics
    • Bastketball
    • Cycling
    • Football
    • Golf
    • Motorsport
      • Formula 1
      • Indycar
      • Nascar
    • Tennis
  • Travel
    • Africa
    • Asia
      • Thiland
    • Europe
    • India
    • Middle East
      • Israel
    • North America
    • South America
    • UK & Ireland
    • United States
  • Login
Search
Close this search box.
  • Sign in
  • News
    • Africa
    • Americas
      • Law
      • Politics
        • 2020 Election
    • Asia
    • Australia
    • Canada
    • China
    • Europe
    • India
    • Latin America
    • Middle East
      • Israel
        • Israel Election
    • Russia
    • UK
  • Economy
    • Business
    • Health
      • Medicine
    • Industrial
    • Markets
    • Real Estate
    • Small Business
    • Startup
  • Science & Technology
    • Apps
    • Cameras
    • Space
    • Computers
    • Phones
    • Gadgets
    • Internet
  • Food & Drinks
    • Restaurants
  • Culture
    • Art
    • Books
    • Celebrity
    • Movies
    • Music
    • TV
  • LifeStyle
    • Autos
    • Fitness
    • Fashion
      • Beauty
    • Design
  • Sports
    • American Football
    • Athletics
    • Bastketball
    • Cycling
    • Football
    • Golf
    • Motorsport
      • Formula 1
      • Indycar
      • Nascar
    • Tennis
  • Travel
    • Africa
    • Asia
      • Thiland
    • Europe
    • India
    • Middle East
      • Israel
    • North America
    • South America
    • UK & Ireland
    • United States
  • Login
Menu
  • Sign in
  • News
    • Africa
    • Americas
      • Law
      • Politics
        • 2020 Election
    • Asia
    • Australia
    • Canada
    • China
    • Europe
    • India
    • Latin America
    • Middle East
      • Israel
        • Israel Election
    • Russia
    • UK
  • Economy
    • Business
    • Health
      • Medicine
    • Industrial
    • Markets
    • Real Estate
    • Small Business
    • Startup
  • Science & Technology
    • Apps
    • Cameras
    • Space
    • Computers
    • Phones
    • Gadgets
    • Internet
  • Food & Drinks
    • Restaurants
  • Culture
    • Art
    • Books
    • Celebrity
    • Movies
    • Music
    • TV
  • LifeStyle
    • Autos
    • Fitness
    • Fashion
      • Beauty
    • Design
  • Sports
    • American Football
    • Athletics
    • Bastketball
    • Cycling
    • Football
    • Golf
    • Motorsport
      • Formula 1
      • Indycar
      • Nascar
    • Tennis
  • Travel
    • Africa
    • Asia
      • Thiland
    • Europe
    • India
    • Middle East
      • Israel
    • North America
    • South America
    • UK & Ireland
    • United States
  • Login
News Online
Search
Close this search box.
  • 29/08/2025 06:19 Want to make change? Let the kids tell their stories | Anshul Tewari
  • 29/08/2025 06:19 Climate progress isn’t a sprint — it’s a marathon | Greg De Temmerman
  • 29/08/2025 04:19 Top Florida official says ‘Alligator Alcatraz’ will likely be empty within days…
  • 29/08/2025 04:19 Jelena Ostapenko after Taylor Townsend confrontation: ‘Never racist in my life’
  • 29/08/2025 04:19 Final game-by-game predictions for the Texas Football 2025 season
  • 29/08/2025 02:19 Crescent Hotels & Resorts Assumes Management of The Westin Jackson
  • 29/08/2025 02:19 4 tips to using AI and not creating slop
  • 29/08/2025 02:19 Is WhatsApp for Hotel Guest Communication Worth It?
  • 29/08/2025 00:19 Bolivia’s Gas Exports at Crossroads After MAS Defeat
  • 29/08/2025 00:19 UK’s Largest Battery Storage Site Secures £1 Billion Private Funding
Leqembi (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
Home » Business » Health » Medicine » Leqembi (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union

Leqembi (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union

Clora Paris 19/04/2025 09:21

TOKYO and CAMBRIDGE, Mass., Apr 18, 2025 – (JCN Newswire) – Eisai Co., Ltd. and Biogen Inc. announced today that the European Commission (EC) has granted the amyloid-beta (Aβ) monoclonal antibody Leqembi® (lecanemab)  Marketing Authorization (MA) in the European Union (EU). This makes the medicine the first therapy that targets an underlying cause of Alzheimer’s

JCN Newswire
TOKYO and CAMBRIDGE, Mass., Apr 18, 2025 – (JCN Newswire) – Eisai Co., Ltd. and Biogen Inc. announced today that the European Commission (EC) has granted the amyloid-beta (Aβ) monoclonal antibody Leqembi® (lecanemab)  Marketing Authorization (MA) in the European Union (EU). This makes the medicine the first therapy that targets an underlying cause of Alzheimer’s disease (AD) to be granted a MA in the EU.1,2Lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment (MCI) and mild dementia due to AD (early AD) who are apolipoprotein E ε4 (ApoE ε4*) non-carriers or heterozygotes with confirmed amyloid pathology.1 The lecanemab MA applies to all 27 EU Member States as well as Iceland…
Read More

About the Author

View all posts by Clora Paris


« Previous Post
Next Post »
Folow Us
  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • Pinterest
  • Instagram
News Live
Popular
Gaza death toll mounts as world leaders intensify calls for lasting ceasefire
Israel
29/08/2025 Comments Off on Gaza death toll mounts as world leaders intensify calls for lasting ceasefire
A Glimpse into Palestine Before Israeli Occupation Refutes Colonial “Empty Land” Myth
Israel
29/08/2025 Comments Off on A Glimpse into Palestine Before Israeli Occupation Refutes Colonial “Empty Land” Myth
Editor picks

These Are the Best Labor Day Tech Deals on Amazon

29/08/2025 Daniel Oropeza

Amazon's Labor Day sale is in full swing, with sales on TVs, headphones, tablets, speakers, and more...

The best Labor Day TV sales

29/08/2025 Brandt Ranj

Labor Day weekend marks the unofficial end of summer, which is a bit sad, but it’s a great time to

Never plug these 8 gadgets into your smart TV’s USB port

29/08/2025 Maribel Mote

Don’t learn the hard way. These are the devices that murder USB ports...

Follow Us
Tweets by @NewsOnlineApp
Like Us
Services

Advertise With Us

Display Advertising

No posts found.

About

About us

Contact us

Privacy Policy

 

© NEWS Online
Scroll to top

This website uses cookies to ensure you get the best experience on our website.

got it
Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset